Patient characteristics (N = 135 patients)
. | Total . | CEBPA+ . | CEBPA− . | P . |
---|---|---|---|---|
No. of patients | 135 | 15 | 120 | |
Median age, y (range) | 45 (15-64) | 45 (22-63) | 45 (15-64) | .59* |
Sex (M/F) | 71/64 | 10/5 | 61/59 | .28† |
WBC, ×109/L (range) | 14 (0.6-400) | 20 (2.2-170) | 13 (0.6-400) | .68* |
FAB subtypes | ||||
M0 | 1 | 0 | 1 | |
M1 | 33 | 8 | 25 | .02‡ |
M2 | 34 | 2 | 32 | |
M4 | 19 | 3 | 16 | |
M5 | 32 | 2 | 30 | |
M6 | 5 | 0 | 5 | |
M7 | 4 | 0 | 4 | |
Unclassified | 7 | 0 | 7 | |
Cytogenetics (MRC classification) | .062-153 | |||
Favorable | 15 | 0 | 15 | |
t(8;21) | 9 | 0 | 9 | |
Inv(16) | 6 | 0 | 6 | |
Intermediate | 91 | 15 | 76 | |
Adverse | 14 | 0 | 14 | |
Undetermined | 15 | 0 | 15 | |
FLT3status | .54† | |||
Wild type | 99 | 10 | 89 | |
ITD | 35 | 5 | 30 | |
Induction arm | .79† | |||
Standard 3 + 7 | 45 | 6 | 39 | |
Double induction | 47 | 4 | 43 | |
Timed-sequential induction | 43 | 5 | 38 |
. | Total . | CEBPA+ . | CEBPA− . | P . |
---|---|---|---|---|
No. of patients | 135 | 15 | 120 | |
Median age, y (range) | 45 (15-64) | 45 (22-63) | 45 (15-64) | .59* |
Sex (M/F) | 71/64 | 10/5 | 61/59 | .28† |
WBC, ×109/L (range) | 14 (0.6-400) | 20 (2.2-170) | 13 (0.6-400) | .68* |
FAB subtypes | ||||
M0 | 1 | 0 | 1 | |
M1 | 33 | 8 | 25 | .02‡ |
M2 | 34 | 2 | 32 | |
M4 | 19 | 3 | 16 | |
M5 | 32 | 2 | 30 | |
M6 | 5 | 0 | 5 | |
M7 | 4 | 0 | 4 | |
Unclassified | 7 | 0 | 7 | |
Cytogenetics (MRC classification) | .062-153 | |||
Favorable | 15 | 0 | 15 | |
t(8;21) | 9 | 0 | 9 | |
Inv(16) | 6 | 0 | 6 | |
Intermediate | 91 | 15 | 76 | |
Adverse | 14 | 0 | 14 | |
Undetermined | 15 | 0 | 15 | |
FLT3status | .54† | |||
Wild type | 99 | 10 | 89 | |
ITD | 35 | 5 | 30 | |
Induction arm | .79† | |||
Standard 3 + 7 | 45 | 6 | 39 | |
Double induction | 47 | 4 | 43 | |
Timed-sequential induction | 43 | 5 | 38 |